{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:15:06Z","timestamp":1778818506532,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clbc.2026.02.015","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:01:44Z","timestamp":1771952504000},"page":"158-170.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7375-4346","authenticated-orcid":false,"given":"Danilo","family":"Giffoni M M Mata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Italo","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Smith-Uffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Sambhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gehlaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossanna C","family":"Pezo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin K W","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Menjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2026.02.015_bib0001","unstructured":"Breast cancer - World Health Organization. Accessed August 13, 2024, Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer"},{"key":"10.1016\/j.clbc.2026.02.015_bib0002","unstructured":"Global cancer burden growing, amidst mounting need for services. Accessed August 13, 2024, Available at: https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing\u2013amidst-mounting-need-for-services"},{"key":"10.1016\/j.clbc.2026.02.015_bib0003","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/0284186X.2017.1407496","article-title":"Influence of specific comorbidities on survival after early-stage breast cancer","volume":"57","author":"Ewertz","year":"2018","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.clbc.2026.02.015_bib0004","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/ijc.31974","article-title":"Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer","volume":"144","author":"Minicozzi","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2026.02.015_bib0005","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1445-2197.2005.03515.x","article-title":"Is age at diagnosis an independent prognostic factor for survival following breast cancer?","volume":"75","author":"Jayasinghe","year":"2005","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.clbc.2026.02.015_bib0006","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.320.7233.474","article-title":"Factors influencing the effect of age on prognosis in breast cancer: population-based study commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer","volume":"320","author":"Kroman","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2026.02.015_bib0007","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.3390\/curroncol31080335","article-title":"The omission of anthracycline chemotherapy in women with early HER2-negative breast cancer-a systematic review and meta-analysis","volume":"31","author":"Giffoni de Mello Morais Mata","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clbc.2026.02.015_bib0008","unstructured":"World Health Organization (WHO) social determinants of health. https:\/\/www.who.int\/health-topics\/social-determinants-of-health#tab=tab_1"},{"key":"10.1016\/j.clbc.2026.02.015_bib0009","article-title":"A healthy, productive Canada: a determinant of health approach. Final report of the senate subcommittee on population health","year":"2009","journal-title":"Senate Canada"},{"key":"10.1016\/j.clbc.2026.02.015_bib0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-019-05340-7","article-title":"Social determinants of breast cancer risk, stage, and survival","volume":"177","author":"Coughlin","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.02.015_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1354717","article-title":"Social determinants of health and health inequities in breast cancer screening: a scoping review","volume":"12","author":"Jhumkhawala","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.clbc.2026.02.015_bib0012","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ogc.2013.06.001","article-title":"Health disparities in breast cancer","volume":"40","author":"Brawley","year":"2013","journal-title":"Obstetr Gynecol Clin"},{"key":"10.1016\/j.clbc.2026.02.015_bib0013","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-017-4490-3","article-title":"Socioeconomic status and breast cancer treatment","volume":"167","author":"Dreyer","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.02.015_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-024-11129-2","article-title":"Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: a scoping review","volume":"24","author":"Bourgeois","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.clbc.2026.02.015_bib0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/cancers15030604","article-title":"Barriers to breast cancer-screening adherence in vulnerable populations","volume":"15","author":"Ponce-Chazarri","year":"2023","journal-title":"Cancers"},{"issue":"9_Supplement","key":"10.1016\/j.clbc.2026.02.015_bib0016","doi-asserted-by":"crossref","first-page":"B006","DOI":"10.1158\/1538-7755.DISP24-B006","article-title":"Abstract B006: reduced survival outcomes in lower income quintile groups for women with breast cancer treated with chemotherapy in Ontario, Canada","volume":"33","author":"Mata","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"key":"10.1016\/j.clbc.2026.02.015_bib0017","first-page":"12","article-title":"Social determinants of lung cancer incidence in Canada: A 13-year prospective study","volume":"26","author":"Mitra","year":"2015","journal-title":"Health Rep"},{"key":"10.1016\/j.clbc.2026.02.015_bib0018","first-page":"359","article-title":"Inequity in access to cancer care: a review of the Canadian literature","volume":"22","author":"Maddison","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clbc.2026.02.015_bib0019","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/cncr.29838","article-title":"Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario\u2019s experience","volume":"122","author":"Kumachev","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2026.02.015_bib0020","unstructured":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. STROBE checklist for cohort studies. Accessed October 18, 2022, Available at: https:\/\/www.strobe-statement.org\/checklists\/"},{"key":"10.1016\/j.clbc.2026.02.015_bib0021","unstructured":"ICES - Institute for Clinical Evaluative Sciences). Accessed October 18, 2022, Available at: https:\/\/www.ices.on.ca\/"},{"key":"10.1016\/j.clbc.2026.02.015_bib0022","series-title":"Equity Stratification | Income Stratifier: Guidance on Measuring and Reporting Health Inequalities Definition Construct: Relative income","year":"2022"},{"key":"10.1016\/j.clbc.2026.02.015_bib0023","first-page":"1","article-title":"Correlation between Charlson comorbidity index and surgical prognosis in elderly patients with femoral neck fractures: a retrospective study","volume":"25","author":"Wang","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clbc.2026.02.015_bib0024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jssam\/smad034","article-title":"Joint imputation of general data","volume":"12","author":"Robbins","year":"2023","journal-title":"J Surv Stat Methodol"},{"key":"10.1016\/j.clbc.2026.02.015_bib0025","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.3390\/curroncol29070394","article-title":"Appraising adjuvant endocrine therapy in hormone receptor positive HER2-negative breast cancer: a literature review","volume":"29","author":"Mata","year":"2022","journal-title":"Current Oncology"},{"key":"10.1016\/j.clbc.2026.02.015_bib0026","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1148\/rg.2018180047","article-title":"breast cancer tissue markers, genomic profiling, and other prognostic factors: a primer for radiologists","volume":"38","author":"Tirada","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.clbc.2026.02.015_bib0027","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clbc.2026.02.015_bib0028","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.breast.2021.02.009","article-title":"Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis","volume":"57","author":"Salvo","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2026.02.015_bib0029","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-017-4490-3","article-title":"Socioeconomic status and breast cancer treatment","volume":"167","author":"Dreyer","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.02.015_bib0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-019-05340-7","article-title":"Social determinants of breast cancer risk, stage, and survival","volume":"177","author":"Coughlin","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.02.015_bib0031","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16499","article-title":"neighborhood deprivation and breast cancer mortality among Black and White Women","volume":"7","author":"Barber","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clbc.2026.02.015_bib0032","article-title":"Socioeconomic status and survival after an invasive breast cancer diagnosis","volume":"117","author":"Sprague","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2026.02.015_bib0033","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.whi.2015.02.004","article-title":"Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities","volume":"25","author":"Horner-Johnson","year":"2015","journal-title":"Women\u2019s Health Issues"},{"key":"10.1016\/j.clbc.2026.02.015_bib0034","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-08498-8","article-title":"Associations of health literacy with socioeconomic position, health risk behavior, and health status: a large national population-based survey among Danish adults","volume":"20","author":"Svendsen","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clbc.2026.02.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/21501319221147126","article-title":"Distance and transportation barriers to colorectal cancer screening in a rural community","volume":"14","author":"Lee","year":"2023","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.clbc.2026.02.015_bib0036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40980-018-0045-4","article-title":"Transportation infrastructures and socioeconomic statuses: a spatial regression analysis at the county level in the continental United States, 1970-2010","volume":"7","author":"Kasu","year":"2019","journal-title":"Spat Demogr"},{"key":"10.1016\/j.clbc.2026.02.015_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102598","article-title":"The association between neighborhood socioeconomic status and the risk of incidence and mortality of colorectal cancer: a systematic review and meta-analysis of 1,678,582 participants","volume":"91","author":"Jalili","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clbc.2026.02.015_bib0038","doi-asserted-by":"crossref","first-page":"m4087","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2026.02.015_bib0039","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.3390\/jcm12134502","article-title":"delays in initiating anti-cancer therapy for early-stage breast cancer\u2014how slow can we go?","volume":"12","author":"Abdel-Razeq","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.clbc.2026.02.015_bib0040","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1002\/cncr.33121","article-title":"Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women","volume":"126","author":"Emerson","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2026.02.015_bib0041","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251341520","article-title":"Socioeconomic status and breast cancer treatment in the United States: results from a systematic literature review","volume":"32","author":"Akkala","year":"2025","journal-title":"Cancer Control"},{"key":"10.1016\/j.clbc.2026.02.015_bib0042","unstructured":"Income factsheet overview-What do economic statistics tell us? Accessed December 26, 2024, Available at:https:\/\/www.ruralontarioinstitute.ca\/uploads\/userfiles\/files\/Rural%20Ontario%20Facts%20-%20%20Income%20Factsheet.pdf?utm_campaign=RuralONFacts&utm_source=chatgpt.com"},{"key":"10.1016\/j.clbc.2026.02.015_bib0043","series-title":"Northern Policy Institute: A Tale of Ten Cities: Comparing Key Costs for a Family of Four in Urban Areas of Northern and Southern Ontario","author":"Noga","year":"2020"},{"key":"10.1016\/j.clbc.2026.02.015_bib0044","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/sj.bjc.6605949","article-title":"A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status","volume":"103","author":"Louwman","year":"2010","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.clbc.2026.02.015_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-017-4490-3","article-title":"Socioeconomic status and breast cancer treatment","volume":"167","author":"Dreyer","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.02.015_bib0046","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/0284186X.2021.1995892","article-title":"Socioeconomic disparities in the prevalence of comorbid chronic conditions among Canadian adults with cancer","volume":"61","author":"Abdel-Rahman","year":"2022","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.clbc.2026.02.015_bib0047","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1016\/S2666-7568(23)00195-2","article-title":"Socioeconomic inequalities in physical, psychological, and cognitive multimorbidity in middle-aged and older adults in 33 countries: a cross-sectional study","volume":"4","author":"Ni","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.clbc.2026.02.015_bib0048","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.clbc.2026.02.015_bib0049","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bja.2023.06.054","article-title":"Propensity score methods in observational research: brief review and guide for authors","volume":"131","author":"Andrew","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clbc.2026.02.015_bib0050","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2026.02.015_bib0051","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2026.02.015_bib0052","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2026.02.015_bib0053","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free Survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:56:10Z","timestamp":1778817370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1526820926000303"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.02.015","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced Survival Outcomes in Socioeconomically Disadvantaged Women With HER2-Negative Breast Cancer Undergoing Chemotherapy in Canada","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}